Skip to main content

Loading market data...

HCA

HCA Healthcare, Inc.

NYSE • United states

$465.75

+$10.87

(+2.39%)

Source: Yahoo Finance · Quote time Oct 20, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

HCA Healthcare, Inc. (HCA)

Unavailable

Quotes may be delayed

$100.84B

Market Cap

1,315,350

Volume

14.8

P/E Ratio

0.66%

Div Yield

HCA Healthcare, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: ONE PARK PLZ, NASHVILLE, TN
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

29 Jul 2026

HCA Healthcare, Inc. reported A material financing obligation

HCA Healthcare, Inc. filed an 8-K covering a material financing obligation, another company event.

28 Jul 2026

HCA Healthcare, Inc. filed Form 10-Q

HCA Healthcare, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

24 Jul 2026

HCA Healthcare, Inc. reported Operating or financial results

HCA Healthcare, Inc. filed an 8-K covering operating or financial results, Regulation FD disclosure, another company event, supporting financial statements or exhibits.

14 Jul 2026

HCA Healthcare, Inc. reported Operating or financial results

HCA Healthcare, Inc. filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.

18 Jun 2026

HCA Healthcare, Inc. reported A director or senior management change or compensation event

HCA Healthcare, Inc. filed an 8-K covering a director or senior management change or compensation event.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$940.00M

Total assets (USD)$61.45B

Total liabilities (USD)$45.62B

Shareholders' equity (USD)−$6.30B

Long-term debt (USD)$39.49B

Debt due within a year (USD)$8.53B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 31 Mar 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q1 2026	$19.11B	Unavailable	$1.62B	$7.15	10-Q · 29 Apr 2026
Q4 2025	$19.51B	Unavailable	$1.88B	Unavailable	10-K · 10 Feb 2026
Q3 2025	$19.16B	Unavailable	$1.64B	$6.96	10-Q · 30 Oct 2025
Q2 2025	$18.61B	Unavailable	$1.65B	$6.83	10-Q · 4 Aug 2025
Q1 2025	$18.32B	Unavailable	$1.61B	$6.45	10-Q · 1 May 2025
Q4 2024	$18.29B	Unavailable	$1.44B	Unavailable	10-K · 14 Feb 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $455.16

-2.3% upside potential

📈

Strong Buy

Unavailable

👍

Buy

13

⏸️

Hold

7

📉

Sell

1

21 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 11:50 UTC Targets range 380.00–579.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

26

Aug 2026

McAlevey Michael R

EVP & Chief Legal & Admin Off.

Other

$429.00 per share

7,769 shares

7

May 2026

Marks Mike A

EVP and CFO

Gift

Unavailable per share

6,672 shares

28

Apr 2026

Frist William R

Director

Grant or award

Unavailable per share

809 shares

28

Apr 2026

FRIST THOMAS F III

Director

Grant or award

Unavailable per share

1,041 shares

28

Apr 2026

Smith Andrea B

Director

Grant or award

Unavailable per share

509 shares

28

Apr 2026

Riley Wayne Joseph

Director

Grant or award

Unavailable per share

509 shares

28

Apr 2026

MICHELSON MICHAEL W

Director

Grant or award

Unavailable per share

925 shares

28

Apr 2026

Johnston Hugh F

Director

Grant or award

Unavailable per share

809 shares

Top Shareholders

Vanguard Group Inc

14,716,173 shares

-1.198% change

12/31/2025

Blackrock, Inc.

13,003,600 shares

-2.691% change

6/30/2026

Vanguard Capital Management Llc

10,141,708 shares

-0.36% change

6/30/2026

Sanders Capital, Llc

8,828,287 shares

-1.439% change

6/30/2026

State Street Corp

7,469,035 shares

-0.935% change

6/30/2026

Wellington Management Group Llp

4,707,473 shares

20.466% change

6/30/2026

Geode Capital Management, Llc

3,668,008 shares

-0.664% change

6/30/2026

First Eagle Investment Management, Llc

3,295,565 shares

1.26% change

6/30/2026

Vanguard Portfolio Management Llc

2,712,828 shares

-1.63% change

6/30/2026

Morgan Stanley

2,586,771 shares

12.719% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 11:50 UTC· 22 hours ago

Research coverage and investment tools

HCA Healthcare, Inc. (HCA) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Hospital/Nursing Management). Its last price was US$465.75 on 20 Oct 2026. That is 55% of the way from its 52-week low of US$353.99 to its 52-week high of US$556.52. It paid US$3.06 a share in dividends over the last 12 months, a dividend yield of 0.66%. The latest ex-dividend date on file is 16 Sep 2026. Its market capitalisation was US$100.84 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q1 2026	$19.11B	Unavailable	$1.62B	$7.15	—	—	$895.00M	10-Q · 29 Apr 2026 (opens in a new tab)
Q4 2025	$19.51B	Unavailable	$1.88B	Unavailable	—	—	$870.00M	10-K · 10 Feb 2026 (opens in a new tab)
Q3 2025	$19.16B	Unavailable	$1.64B	$6.96	—	—	$3.13B	10-Q · 30 Oct 2025 (opens in a new tab)
Q2 2025	$18.61B	Unavailable	$1.65B	$6.83	—	—	$3.03B	10-Q · 4 Aug 2025 (opens in a new tab)
Q1 2025	$18.32B	Unavailable	$1.61B	$6.45	—	—	$660.00M	10-Q · 1 May 2025 (opens in a new tab)
Q4 2024	$18.29B	Unavailable	$1.44B	Unavailable	—	—	$1.27B	10-K · 14 Feb 2025 (opens in a new tab)

Cash and equivalents: $940.00M
Total assets: $61.45B
Total liabilities: $45.62B
Shareholders' equity: −$6.30B
Long-term debt: $39.49B
Debt due within a year: $8.53B

8-K · 29 Jul 2026 · Financing

HCA Healthcare, Inc. reported A material financing obligation (opens in a new tab)

HCA Healthcare, Inc. filed an 8-K covering a material financing obligation, another company event.
10-Q · 28 Jul 2026

HCA Healthcare, Inc. filed Form 10-Q (opens in a new tab)

HCA Healthcare, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 24 Jul 2026

HCA Healthcare, Inc. reported Operating or financial results (opens in a new tab)

HCA Healthcare, Inc. filed an 8-K covering operating or financial results, Regulation FD disclosure, another company event, supporting financial statements or exhibits.
8-K · 14 Jul 2026

HCA Healthcare, Inc. reported Operating or financial results (opens in a new tab)

HCA Healthcare, Inc. filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 18 Jun 2026 · Management change

HCA Healthcare, Inc. reported A director or senior management change or compensation event (opens in a new tab)

HCA Healthcare, Inc. filed an 8-K covering a director or senior management change or compensation event.

Insider	Date	Transaction	Shares	Average price	Filing
McAlevey Michael R EVP & Chief Legal & Admin Off.	26 Aug 2026	Other (J)	−7,769	$429.00	Form 4 (opens in a new tab)
Marks Mike A EVP and CFO	7 May 2026	Gift (G)	−6,672	—	Form 4 (opens in a new tab)
Frist William R Director	28 Apr 2026	Grant or award (A)	+809	—	Form 4 (opens in a new tab)
FRIST THOMAS F III Director	28 Apr 2026	Grant or award (A)	+1,041	—	Form 4 (opens in a new tab)
Smith Andrea B Director	28 Apr 2026	Grant or award (A)	+509	—	Form 4 (opens in a new tab)
Riley Wayne Joseph Director	28 Apr 2026	Grant or award (A)	+509	—	Form 4 (opens in a new tab)
MICHELSON MICHAEL W Director	28 Apr 2026	Grant or award (A)	+925	—	Form 4 (opens in a new tab)
Johnston Hugh F Director	28 Apr 2026	Grant or award (A)	+809	—	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	14,716,173	-1.198%
Blackrock, Inc.	6/30/2026	13,003,600	-2.691%
Vanguard Capital Management Llc	6/30/2026	10,141,708	-0.36%
Sanders Capital, Llc	6/30/2026	8,828,287	-1.439%
State Street Corp	6/30/2026	7,469,035	-0.935%
Wellington Management Group Llp	6/30/2026	4,707,473	20.466%
Geode Capital Management, Llc	6/30/2026	3,668,008	-0.664%
First Eagle Investment Management, Llc	6/30/2026	3,295,565	1.26%
Vanguard Portfolio Management Llc	6/30/2026	2,712,828	-1.63%
Morgan Stanley	6/30/2026	2,586,771	12.719%

Previous close: 454.88 USD
Day range: 455.00 – 466.05 USD
52-week range: 353.99 – 556.52 USD
Volume: 1,315,350
Market cap: $100.84B
Average volume: 2,058,995
P/E ratio: 14.8
EPS (FY 2025, diluted): 28.33 USD
Dividends (last 12 months): 3.06 USD
Dividend yield: 0.66%
Ex-dividend date: 16 Sep 2026
Shares outstanding: 216.50M
Beta (5Y monthly): 1.12

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 20:00 UTC· 1 day ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 08:08 UTC· 2 hours ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 08:08 UTC· 2 hours ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for HCA yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.